No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
COVID-19 Vaccines / adverse effects
-
COVID-19* / prevention & control
-
Humans
-
Neoplasms*
-
RNA, Messenger
-
SARS-CoV-2
-
Seroconversion
Substances
-
COVID-19 Vaccines
-
RNA, Messenger